Wilmington, Delaware, United States, July 15, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: According to the prostate cancer therapeutics market outlook by Transparency Market Research (TMR), the global prostate cancer therapeutics market is estimated to register growth at a CAGR of 6.9% during the forecast period, from 2022 to 2031. Hence, the market is prognosticated to gain a valuation of over US$ 21.7 Bn by 2031.
The TMR study offers panoramic view of the global prostate cancer therapeutics market. Hence, it provides in-depth analysis on key facets such as the growth drivers, challenges, growth opportunities, and recent developments in the prostate cancer therapeutics market. This study also sheds light on the fastest growing market for prostate cancer therapeutics.
Companies operating in the prostate cancer therapeutics market are using varied strategies such as collaborations, mergers, and acquisitions in order to stay ahead of the market competition. Moreover, they are also seen engaged in product approvals and new product launches in order to expand their product portfolios. Such factors are likely to play important role in the growth of the prostate cancer therapeutics market in the forthcoming years.
Request Brochure of Prostate Cancer Therapeutics Market Research Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6562
Prostate Cancer Therapeutics Market: Key Findings
- Prostate cancer is the most common non-cutaneous cancer globally. Some of the key factors responsible for increase in the number of patients with this cancer type include the sedentary lifestyle of the population in industrialized nations, older population, and early beginning of urological disease. Hence, a rise in the number of people suffering from this cancer type is creating business opportunities in the prostate cancer therapeutics market.
- At present, there are varied prostate cancer therapeutics available in the market including the chemotherapy, hormone therapy, targeted therapy, and biologic therapy. Among all, the adoption of the hormone therapy is being increasing in the recent years owing to the ability of this therapy to reduce the possibilities of cancer reoccurrence as well as to stop or slow down its development. This, in turn, is expected to help in the expansion of the global prostate cancer therapeutics market during the forecast period.
- The government authorities of several nations are taking initiatives to support different R&D projects intended for offering patient-centric care. As a result, leading players in the prostate cancer therapeutics market are increasing concentration on the development of innovative and effectual medications and treatment solutions for this disease. This factor, is turn, is leading to rapid growth in the prostate cancer therapeutics market.
Request for Analysis of COVID-19 Impact on Prostate Cancer Therapeutics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=6562
Prostate Cancer Therapeutics Market: Growth Boosters
- Surge in the number of prostate cancer cases across the globe is expected to result into increase in the future market demand for prostate cancer therapeutics
- Increase in the adoption of the hormone therapy in the prostate cancer treatment is boosting the market growth
Prostate Cancer Therapeutics Market: Regional Analysis
- The prostate cancer therapies market in North America is projected to gain lucrative avenues during the forecast period owing to a rise in the cases of prostate cancer and the presence of key players in the region
- The market is expected to attract sizable revenue-generation avenues in Europe due to the high prevalence of prostate cancer and increase in understanding on the disease in the region
Get Exclusive PDF Sample Copy of Prostate Cancer Therapeutics Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6562
Prostate Cancer Therapeutics Market: Key Players
Some of the key players profiled in the report are:
- Amgen, Inc.
- AbbVie, Inc.
- Bayer AG
- AstraZeneca
- Endo Pharmaceuticals, Inc.
- Dendreon Pharmaceuticals LLC
- Johnson & Johnson Services
- Ipsen Pharma
- Sanofi
- Pfizer, Inc.
Make an Enquiry Before Buying –https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=6562
Prostate Cancer Therapeutics Market Segmentation
- Therapy
- Hormone Therapy
- Luteinizing Hormone-releasing Hormone Analogs
- Luteinizing Hormone-releasing Hormone Antagonists
- Antiandrogens
- Chemotherapy
- Systemic Chemotherapy
- Regional Chemotherapy
- Biologic Therapy
- Targeted Therapy
- Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Others
Regions Covered
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Cancer Immunotherapy Market: Cancer immunotherapy market is driven by increase in R&D activities, improvements in efficacy & accuracy of newer medicines, surge in adoption of target therapy over standard therapy, and rise in prevalence of cancer are the major factors propelling the global market.
Cervical Cancer Diagnostic Tests Market: Cervical cancer diagnostic tests market is driven by increase in awareness about cancer diagnosis in the early stages and rise in demand for diagnostic & advanced screening techniques drive the global market.
HER2 Breast Cancer Test Market: Rise in prevalence of breast cancer across the globe is projected to drive the global HER2 breast cancer test market during the forecast period. Breast cancer in women is a primary health burden globally.
Hyperthermia Cancer Treatment Market: Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment.
Cancer Diagnostics Market: Increasing trend for preventive diagnosis due to escalating prevalence continues, early diagnosis enables better clinical and economical outcomes for patients are projected to drive the global cancer diagnostics market during the forecast period
Head and Neck Cancer Market: Head and neck cancer market is driven by increase in the patient population, rise in health care infrastructure in developing economies, growth of the pharmaceutical industry, surge in research and development activity, increase in product approvals, and rise in government initiatives.
Radiation Therapy Market: Rise in preference for non-invasive treatment procedures is creating lucrative opportunities for players in the global radiation therapy market.
Particle Therapy Market: The global particle therapy market is expected to be driven by rise in prevalence of cancer, low risk of treatment-induced disorders, and increase in the number of particle therapy centers across the world.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
